These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2483573

  • 21. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K, Bestehorn HP, Roskamm H.
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [Abstract] [Full Text] [Related]

  • 22. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
    Frisk-Holmberg M, Juhlin-Dannfelt A, Aström H.
    Clin Physiol; 1985 Jun; 5(3):231-42. PubMed ID: 2860992
    [Abstract] [Full Text] [Related]

  • 23. Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension.
    Gregorini L, Perondi R, Grassi G, Saino A, Giannattasio C, Mancia G, Zanchetti A.
    J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 10():S126-8. PubMed ID: 2455112
    [Abstract] [Full Text] [Related]

  • 24. Chronic hemodynamic effects of tiapamil and felodipine in essential hypertension at rest and during exercise.
    Lund-Johansen P, Omvik P.
    J Cardiovasc Pharmacol; 1990 Jun; 15 Suppl 4():S42-7. PubMed ID: 1693726
    [Abstract] [Full Text] [Related]

  • 25. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
    van Baak MA, Böhm RO, Arends BG, van Hooff ME, Rahn KH.
    Int J Sports Med; 1987 Oct; 8(5):342-7. PubMed ID: 2890591
    [Abstract] [Full Text] [Related]

  • 26. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
    Aoki K, Sato K.
    Arzneimittelforschung; 1982 Oct; 32(9):1141-5. PubMed ID: 6756418
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 29. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV, Chmir VP, Krasovskaia EA, Malanchuk TA, Polishchuk II, Iashchenko OB.
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [Abstract] [Full Text] [Related]

  • 30. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M, Edelmann F, Knapp M, Schön S, Schwencke C, Simonis G, Borst M, Weinbrenner C, Strasser RH.
    Int J Cardiol; 2009 Feb 20; 132(2):248-56. PubMed ID: 18579230
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R, Bender F, Gülker H, Specker E, Molinski M.
    Z Kardiol; 1984 Aug 20; 73(8):498-503. PubMed ID: 6495809
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov 20; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 35. Comparative studies of calcium-channel blockers and beta-blockers in essential hypertension: clinical implications.
    Massie BM, Tubau JF, Szlachcic J.
    Circulation; 1987 Jun 20; 75(6 Pt 2):V163-9. PubMed ID: 2882873
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Heterogeneity of hemodynamic parameters in untreated primary hypertension, and individualization of antihypertensive therapy based on noninvasive hemodynamic measurements.
    Aoka Y, Hagiwara N, Kasanuki H.
    Clin Exp Hypertens; 2013 Jun 20; 35(1):61-6. PubMed ID: 22681554
    [Abstract] [Full Text] [Related]

  • 39. Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.
    Reale A, Nigri A, Gioffrè PA, Motolese M.
    Eur J Cardiol; 1979 Feb 20; 9(2):101-9. PubMed ID: 32041
    [Abstract] [Full Text] [Related]

  • 40. Hemodynamic profiles of antihypertensive agents.
    Lund-Johansen P.
    Blood Press Suppl; 1992 Feb 20; 1():16-22; discussion 23. PubMed ID: 1343266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.